What are the potential benefits of Thymulin?

T-cell development and maturation support in the thymus. Anti-inflammatory via NF-κB inhibition and cytokine modulation. Prevention of overproduction of pro-inflammatory cytokines in sepsis models. Restoration of T-cell counts in immunosenescent animals. Vaccine adjuvant activity enhancing antibody responses in aged mice. Reduced severity in autoimmune encephalomyelitis (MS model). Bidirectional neuroendocrine-immune communication

What compounds work synergistically with Thymulin?

Thymulin has been studied alongside Zinc, Thymosin Alpha-1, Vilon for potential synergistic effects.

Thymulin — Mechanism, Benefits, Research & Synergies

Overview

Thymulin (facteur thymique sérique, FTS) is a nonapeptide hormone produced exclusively by thymic epithelial cells, characterized by its unique zinc-binding requirement for biological activity. Thymulin circulates in blood in free (inactive) and zinc-bound (active) forms. Its levels decline progressively from adolescence through advanced age, correlating with thymic involution and immunosenescence. Research demonstrates roles in T-cell maturation, anti-inflammatory cytokine regulation, NF-κB modulation, and potential thymic rejuvenation in aging.

Mechanism of Action

Thymulin binds to T-cell surface receptors (zinc-dependent interaction) activating calcium signaling, MAPK pathway activation, and downstream transcription factor nuclear translocation influencing T-cell survival, differentiation, and cytokine production. It modulates NF-κB signaling (IKK phosphorylation inhibition) reducing inflammatory cytokines including IL-1β, IL-2, IL-6, TNF-alpha, IFN-gamma. It also suppresses HSP70 overproduction in inflammatory states. Zinc coordination through specific amino acid residues is essential for receptor binding.

Potential Benefits

T-cell development and maturation support in the thymus
Anti-inflammatory via NF-κB inhibition and cytokine modulation
Prevention of overproduction of pro-inflammatory cytokines in sepsis models
Restoration of T-cell counts in immunosenescent animals
Vaccine adjuvant activity enhancing antibody responses in aged mice
Reduced severity in autoimmune encephalomyelitis (MS model)
Bidirectional neuroendocrine-immune communication

Research Dosage Notes

The following reflects doses used in published research studies. This is not medical advice.

Animal studies: 15 mcg/100g body weight intraperitoneally. Clinical context: low microgram range subcutaneous injections. Zinc sufficiency is required for biological activity.

Amino Acid Sequence

Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (with pyroglutamic acid N-terminus, zinc-bound)

Side Effects & Safety

Generally well-tolerated at therapeutic doses
Low toxicity profile
Injection site reactions

Synergistic Compounds

The following compounds have been studied alongside Thymulin for potential complementary or synergistic effects:

ZincThymosin Alpha-1 Vilon

Learn More

Beginner's GuideNew to peptides? Start here Stacking GuideSynergistic combinations Administration RoutesSubQ, IM, oral, nasal & more Reconstitution CalculatorCalculate exact dosing Peptides vs SARMsFull comparison How Peptides Are MadeSPPS, purification & QC

References & Further Reading

[object Object]
[object Object]
[object Object]

Quick Facts

Molecular Weight	857.0 g/mol (zinc complex ~924 Da)
Research Status	Russian and European preclinical research. Phase I/II explored in various immune conditions. Active research in aging, autoimmunity, and vaccination contexts. Not FDA-approved.

More Peptides in This Category

Thymosin Alpha-1 Vilon LL-37 Vasoactive Intestinal Peptide KPV Thymogen

Thymulin